A probe enables real-time monitoring of agglomeration, coating, and granulation.
The Parsum IPP-80 probe from Malvern Instruments enables inline particle-size measurement for real-time monitoring of agglomeration, coating, and granulation processes. The probe is suitable for powders, pellets, and granules, and a robust, sanitary design includes built-in, self-diagnostic tools that ensure data quality.
Particle size is a performance-defining characteristic. During granulation, for example, control of particle size may be vital to ensure the production of granules that meet the requirements of subsequent processing steps and deliver the required performance in a finished product. Inline particle-size distribution measurement enables robust process monitoring and control. In the pharmaceutical industry, these capabilities support the application of quality by design, scoping of design space, and the development of continuous manufacturing.
The Parsum IPP-80 inline probe provides continuous particle size and size distribution data using the technique of spatial filter velocimetry. Measuring in the range of 50 µm to 6000 µm, the probe is able to analyze powders as well as pellets and large granules. Stable optics mean that the probe is resistant to the effects of vibration and requires no manual alignment. The software includes a range of diagnostic features for measurement verification and self-diagnosis to ensure trouble-free operation and safeguard data quality.
Source: Malvern
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.